The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. According to the announcement, Biodata—a subsidiary of Labat Africa—“is the brainchild of Dr. Quite frankly, the clinical trials couldn’t have come at a better time. I don’t think it works for severe pain.

Clinical Trials

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. billion in 2019. billion in 2019. Over the next several years, the psychedelics industry is expected to grow at a compound annual growth rate of 16.3

Extraction

The Cannigma

MARCH 7, 2022

In a 2019 animal study, CBN isolate was reported to relieve musculoskeletal pain. CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.

THC

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. Adams, CEO.

Clinical Trials

NORML

JANUARY 18, 2019

House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Senator Anna Wishart (D) has re-introduced legislation, LB 110, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.

Legislation

LifeCannMD

JULY 3, 2024

Various clinical trials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms. For example, a 2019 study found that CBD significantly reduced anxiety in teenagers with social anxiety disorder. Some studies have shown promising results, particularly with CBD.

Treatment

The Cannigma

FEBRUARY 2, 2021

Of these consumers, over half said the drug had a beneficial clinical effect on their condition. As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Parkinson’s disease and cannabis.

Patients

CannaMD

APRIL 23, 2020

In December of 2019, the company announced outstanding results in a pre-clinical mouse model of Parkinson’s disease. FDA in order to enter human clinical trial as early as this year! ” However, recent research by GB Sciences marks an important step forward. Find Parkinson’s Disease Relief.

Clinical Trials

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin. It can be a very difficult condition. But we may be on the cusp of having those trials, which would be very exciting.

Cannabinoids

Veriheal

OCTOBER 13, 2020

Ulcerative Colitis is a condition that causes long-lasting inflammation and ulcers (sores) in the innermost lining of the individual’s large intestine and rectum. Crohn’s Disease is also a condition that causes inflammation, but it affects the lining of the digestive tract, which can then spread deeply into the affected tissues. .

Digestion

Cannabis Law Report

AUGUST 19, 2021

Britain’s Food Standards Agency now regulates the sector and its marketing, after the European Union classified CBD as food in 2019. That was almost a third higher than the UK trade group’s pre-pandemic 2019 projection.

Cannabinoids

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. 3 Nature Aging | VOL 1 | July 2021 | p.

Clinical Trials

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. References Staff, T.

Conditions

Cannabis Law Report

MARCH 21, 2019

If you reside in any of the following 15 states, there are laws stating certain conditions must be met in order to legally obtain CBD. Georgia only allows patients diagnosed with cancer, ALS, seizures, and other serious medical conditions to legally possess CBD. You can find the list of medical conditions here.

State Laws

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. Introducing the Right to Try Act. The FDA refers to this program as the expanded access program on their website.

Therapy

Cannabis Law Report

DECEMBER 14, 2019

In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. According to Australian marijuana research firm FreshLeaf Analytics, during Q3 of 2019, 76 new products were introduced in the market, up from 54 in Q1. percent interest AusCann, raking in C$6.3

Pharmaceutical

The Cannigma

MAY 9, 2023

However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes. However, the government’s recent announcement of clinical trials on medical cannabis could be a sign of change in the future.

Law

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. The respondents ranged in age from 19 to 81, and 50% identified as White, 20% as Latino, 12% as Asian, and 10% as Black.

Education

Cannabis Law Report

AUGUST 2, 2021

Radicle ACES will use validated, standardized health indices to gather health outcome data from a diverse population across a variety of ethnicities, age groups, geographies, behavioral habits, and pre-existing health conditions. We are delighted to have Lord Jones involved in the Radicle Sciences’ ACES study.

CBD

Cannabis Law Report

JUNE 19, 2022

Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. However, we need rigorous clinical trials to ensure that this promise is realised. June 14, 2022 02:00 AM Eastern Daylight Time. Ksana Health – www.ksanahealth.com.

Clinical Trials

SpeedWeed

MARCH 13, 2021

However, Michigan law requires that the treasury department use that revenue to “provide $20 million annually to one or more clinical trials … researching the efficacy of marihuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”. View original article.

Clinical Trials

Cannabis Law Report

JULY 9, 2021

Denver, Colorado was the first jurisdiction to decriminalize the use of psilocybin via ballot initiative in May 2019. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way.

Law

The Cannigma

OCTOBER 14, 2022

Recreational cannabis is not legal, despite a 2019 citizen’s initiative that called for legalization. In 2019 the Parliament approved a citizen’s proposal to regulate recreational use of cannabis, but backtracked in March 2020 , saying they would wait to follow the lead of Italy. Is weed legal in San Marino? Is CBD legal in San Marino?

Law

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. On March 5, 2019, the U.S. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*.

Clinical Trials

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Event details below: Date: Tuesday, September 17th 2019. MONTREAL and SMITHS FALLS, ON, Sept. Time: 9:00AM to 5:00PM. ABOUT SPECTRUM THERAPEUTICS.

Programs

PrestoDoctor

SEPTEMBER 15, 2023

Obsessive-Compulsive Disorder (OCD) is a debilitating mental health condition that is characterized by intrusive thoughts and compulsive behaviors. Understanding OCD Obsessive-Compulsive Disorder (OCD) is a mental health condition that affects millions of individuals worldwide. These obsessions can vary greatly from person to person.

Research and Development

Cannabis Law Report

OCTOBER 20, 2021

Supreme Court’s 2019 decision in Tennessee Wine & Spirits Retailers Association v. A House subcommittee asked the Department of Veterans Affairs directors why they didn’t support a bipartisan bill ordering the department to conduct clinical trials on the potential benefits of medical marijuana. Thomas, which said Tenn.

Hemp

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . CBD and Immunosuppressant Medications. 2014): 86-95.

CBD

SpeedWeed

MARCH 30, 2021

Anthony Ordman is Honorary Medical Director of Integro Medical Clinics – one of the 20-plus private clinics to have emerged since the law change in 2018. He would like to see the registry opened up to the private sector and believes the restricted conditions available for treatment through the NHS will limit its effectiveness.

Data

SpeedWeed

JULY 31, 2021

On the map, Ohio’s neighbor to the northwest, Michigan began commercial sales of adult-use cannabis in December 2019 and has attracted Ohioans’ business since. As for criminal justice reform, Ohio’s jails and prisons incarcerated 68,528 people in 2019. In Colorado , cannabis arrests plummeted 68% from 2012 to 2019.

Legalization

Project CBD

FEBRUARY 28, 2023

Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7 Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. million on these products.

CBD

Cannabis Law Report

JULY 6, 2021

In 2019, Dr. Johnson received the R. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” Brinkley Smithers award from the American Association of Addiction Medicine. ” About Ehave, Inc. Ehave, Inc. Forward-Looking Statement Disclaimer.

Research and Development

The Joint Blog

JANUARY 23, 2020

” The systematic review of the literature “was conducted during 2019, assessing the data from all case studies and clinical trials involving medicinal cannabis or plant-derived isolates for all major psychiatric disorders (neurological conditions and pain were omitted).”

Clinical Trials

Cannabis Law Report

JULY 4, 2021

Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. Today, people use CBD products to help with various medical conditions, such as diabetes, Chron’s disease, multiple sclerosis, and arthritis. With CBD, though, the “high” feeling is not created.

THC

The Joint Blog

JANUARY 31, 2021

” According to a study we reported on in late 2019 in the journal Frontiers in Neurol thejointblog.com/study-daily-cbd-use-mitigates-symptoms-of-autism-spectrum-disorder ogy , the twice-daily administration of plant-derived CBD-dominant extracts is associated with symptom improvement in adolescents with autism spectrum disorder (ASD).

Epilepsy

Cannabis Law Report

MARCH 29, 2020

o Technology powered research: Virtual clinical trials and other accelerated technologies that mix the potential of new technologies with cannabis to create research insights quickly and more accurately, are being classified as Cannabis 3.0, triggering new innovations and improved data quality through better user experiences.

Compliance